RISW2025
Back to all people

Yong Ma

FDA
1 appearance in the program

Sessions & presentations

PS02: Advancing Clinical Evidence Generation: AI, Data Governance, and Informatics in Drug Development
Presentation: Use of NLP in FDA's post-marketing drug safety monitoring
Parallel · Thu, Sep 25 , 1:15 PM
Presenting Author
↑